What Is a Nerve Biopsy and How Is It Performed?

A nerve biopsy is a procedure in which a surgeon removes a small piece of a peripheral nerve so that a pathologist can examine it under a microscope. It is reserved for a minority of patients whose nerve problems remain unexplained after blood tests, imaging, and electrical nerve studies have come back inconclusive. The procedure can reveal inflammation, damage patterns, infections, and deposits that no other test can detect, but it comes with real trade-offs: permanent numbness at the biopsy site is expected, and a definitive diagnosis is not guaranteed.

Why a Nerve Biopsy Is Considered

Most people with symptoms of neuropathy, such as numbness, tingling, burning pain, or weakness in the hands and feet, never need a nerve biopsy. The cause is usually identified through a combination of clinical examination, blood work, and nerve conduction studies. A biopsy enters the picture only after those initial investigations fail to explain what is going on and the clinical team suspects a condition that can only be confirmed by looking directly at nerve tissue. Even then, the decision is carefully weighed because many biopsies do not yield a clear-cut pathological diagnosis, and the procedure carries meaningful cost and side effects.¹ The principle is straightforward: all non-invasive workup should be completed and come back negative or inconclusive before anyone picks up a scalpel.²

The conditions that most commonly prompt a nerve biopsy fall into a few categories. Suspected vasculitic neuropathy, where blood vessel inflammation is choking off the nerve’s blood supply, is probably the single most frequent reason. Biopsy is also used when amyloidosis (abnormal protein deposits) is suspected, when leprosy needs to be confirmed or ruled out, or when inflammatory demyelinating conditions are suspected but electrical studies are not quite enough to seal the diagnosis. Tumors growing on or within a nerve are another indication, though the approach differs for those cases.

Which Nerve Gets Biopsied

The sural nerve, which runs behind the outer ankle, is the most commonly chosen target. It is purely sensory, meaning cutting it does not cause muscle weakness, only a patch of numbness on the outer edge of the foot. It is also relatively easy to access through a small incision just above the ankle. For most diagnostic questions, the sural nerve provides an adequate sample.

When vasculitis is the main concern, many centers prefer to biopsy the superficial peroneal nerve instead, which runs along the outer lower leg. Studies have suggested that sampling this nerve, sometimes together with a small piece of the peroneus brevis muscle underneath it, is more sensitive for catching vasculitis than a sural nerve biopsy alone. A study comparing complications in 50 patients found that while peroneal nerve biopsy could produce a larger area of numbness in some patients, other complications were not increased compared to sural nerve biopsy.³ That trade-off, slightly more numbness in exchange for a better chance of catching the diagnosis, is often worth it when the clinical suspicion is strong.

In unusual situations, other nerves may be biopsied. Surgeons occasionally sample a sensory branch in the wrist or forearm when a nerve in that area is specifically affected. For certain rare inflammatory neuropathies that involve the nerve roots near the spine, a lumbar nerve rootlet or a fascicle of the sciatic nerve can be surgically excised, though these are far more invasive procedures reserved for cases where no other approach will provide the answer.⁴

How the Surgical Biopsy Is Done

A standard nerve biopsy is a relatively brief outpatient procedure, typically performed under local anesthesia with or without light sedation. The surgeon makes a small incision over the nerve’s known course, carefully exposes it, and removes a segment usually a few centimeters long. Sometimes only a portion of the nerve’s cross-section (a fascicular biopsy) is taken rather than the entire nerve, which can reduce the size of the resulting sensory deficit. The wound is closed with sutures and dressed, and most patients go home the same day.

Handling the specimen is critical. Nerve tissue is fragile and easily damaged by pinching or twisting, and myelin, the insulating sheath around nerve fibers, deteriorates rapidly once removed from the body. The specimen must be kept damp with saline during and after removal, then fixed or frozen immediately. Poor handling can introduce artifacts that mimic disease under the microscope, potentially leading to misinterpretation.

The tissue is then divided into portions for different laboratory analyses. One portion goes into formalin or another fixative for standard microscopy. Another is snap-frozen for specialized staining techniques, including immunohistochemistry. A third portion may be prepared for electron microscopy, which can reveal ultrastructural details invisible on standard slides. And in some labs, a segment is set aside for a technique called nerve fiber teasing.

What Happens in the Lab

The pathologist’s job is to figure out what kind of damage the nerve has sustained, and the answer is not always obvious. Several complementary techniques are used on the same biopsy specimen.

Standard light microscopy on thin cross-sections lets the pathologist count myelinated nerve fibers, measure their density, and look for signs of inflammation, protein deposits, or abnormal cells. Computer-assisted systems can automate parts of this process: the tissue is stained so that the dark myelin sheaths stand out against a pale background, and an image analysis system identifies and measures individual fibers and their axons.⁵ This morphometry gives an objective picture of how many fibers are present and whether they are abnormally thin or swollen.

Nerve fiber teasing is a painstaking technique where individual fibers are pulled apart under a microscope so that long stretches can be examined. It is particularly useful for distinguishing between the two main patterns of nerve damage. In axonal degeneration, where the nerve fiber itself is dying, the fiber breaks into characteristic oval fragments. In segmental demyelination, where the insulating myelin is stripped away while the fiber survives, the original myelin segments disappear and are replaced by thinner, shorter replacement segments.⁶ This distinction matters because it points toward entirely different categories of disease.

Electron microscopy adds another layer, revealing details like abnormal protein fibrils in amyloidosis or subtle structural changes in the myelin layers that light microscopy misses. Immunohistochemical staining can highlight specific cell types, inflammatory markers, or deposited proteins. In research settings, densities of both myelinated and unmyelinated fibers may be quantified, though unmyelinated fibers are only visible under electron microscopy.⁷

Diagnosing Vasculitis

Vasculitic neuropathy, where inflammation of blood vessels within the nerve cuts off its blood supply, is the condition for which nerve biopsy arguably provides the most unique value. No blood test or imaging study can definitively confirm that vasculitis is the cause of a given patient’s neuropathy. The gold standard is seeing the inflamed, damaged vessels in the tissue itself.

The challenge is that vasculitis is patchy. The inflammation does not affect every blood vessel uniformly, so a biopsy might miss the affected areas by chance. One study found sural nerve biopsy was diagnostic in roughly nine out of ten cases of sensory vasculitic neuropathy, though in a small number of patients, muscle biopsy was needed to clinch the diagnosis.⁸ Other studies have reported lower sensitivities, around 55%, when strict diagnostic criteria are applied.⁹ These differences reflect how much the yield depends on where and how the biopsy is taken, how the tissue is processed, and which diagnostic thresholds the pathologist uses.

Even when biopsy does not meet the strictest criteria for “definite” vasculitis, the pathological findings can still be clinically useful. Suggestive changes, like inflammation around blood vessels combined with signs of nerve fiber death, may be enough to support a clinical diagnosis and justify starting immunosuppressive treatment.¹⁰

The Combined Nerve-and-Muscle Approach

One way to improve the odds of catching vasculitis is to biopsy both a nerve and a nearby muscle through the same incision. The most common combination is the superficial peroneal nerve paired with the peroneus brevis muscle, both accessed through a single cut on the outer lower leg. This combined approach allows the pathologist to examine multiple tissue types, and since vasculitis can be patchy, having two specimens instead of one effectively doubles the chances of finding the inflammatory changes.¹¹

In a study of 70 combined superficial peroneal nerve and peroneus brevis muscle biopsies, roughly 30% showed definite vasculitis. The nerve alone was diagnostic in 90% of those positive cases, and the muscle alone in 50%. But when cases classified as either positive or suspicious for vasculitis were included, the combined sensitivity climbed to about 86% with a specificity of 85%.¹² A separate analysis found that adding muscle biopsy increased the diagnostic yield by about 23% in patients with confirmed vasculitis, and that muscle tissue was actually more likely than nerve tissue to show hemosiderin, a telltale sign of old bleeding from damaged vessels.¹³

The combined approach is not more complicated for the patient; it uses the same incision and adds only modest extra time. For suspected vasculitis, it is increasingly considered the standard at specialized centers.

Beyond Vasculitis

Nerve biopsy plays a role in several other conditions, though its value varies widely.

In chronic inflammatory demyelinating polyneuropathy (CIDP), where the immune system attacks the nerve’s myelin coating, biopsy findings are often suggestive but not specific. Characteristic features include demyelination, clusters of regenerating fibers, immune cell infiltration, and structures called “onion bulbs,” which are concentric layers of support cells that form around repeatedly demyelinated fibers.¹⁴ The problem is that some of these features also appear in other types of neuropathy. One study found no clear difference in the amount of demyelination between CIDP patients and patients with a different, non-inflammatory neuropathy.¹⁵ So biopsy alone cannot diagnose CIDP; it adds one piece to a puzzle that also includes clinical features, nerve conduction patterns, and treatment response. That said, biopsy findings can sometimes tip the balance toward starting immunotherapy when other evidence is borderline, and research has shown that immunotherapy was initiated more frequently after biopsy results came in.¹⁶

In regions where leprosy is prevalent, nerve biopsy remains a crucial diagnostic tool. A 26-year study from Brazil involving over 800 biopsies found that roughly 65% of samples were diagnosed with leprosy. The same dataset revealed the wide range of other diagnoses that nerve biopsy can uncover, including vasculitis, diabetic neuropathy, compression neuropathy, amyloidosis, and rare conditions.¹⁷ In that clinical context, nerve biopsy is not a last resort but a practical frontline tool.

Complications and What Recovery Looks Like

The most common and expected consequence of a nerve biopsy is sensory loss at the site supplied by the biopsied nerve. For a sural nerve biopsy, this means a patch of numbness along the outer edge of the foot. Most patients adapt to this over time, though the numbness is permanent. For peroneal nerve biopsy, the area of numbness can be larger in some patients.³

Less common but more troublesome complications include wound infection, delayed healing, and chronic pain at the biopsy site. In rare cases, the cut nerve end can form a neuroma, a tangled knot of nerve tissue that generates persistent neuropathic pain and may require further treatment.¹⁸ The wound itself is typically small and heals within a couple of weeks, though patients are often advised to keep weight off the leg and avoid strenuous activity for a short period afterward.

It is worth emphasizing that nerve biopsy sacrifices a functioning nerve. You should go in with realistic expectations: the procedure is a diagnostic tool, not a treatment. Its value lies entirely in the information it provides, and that information is only as good as the clinical team’s ability to select the right patients, the right nerve, and the right laboratory techniques.

Ultrasound-Guided Needle Biopsy

The traditional open surgical biopsy is not the only option. Over the past two decades, ultrasound-guided needle biopsy has gained ground, particularly for suspected nerve tumors. In this approach, a radiologist uses ultrasound imaging to guide a needle into the nerve or nerve-associated mass and extract a small tissue core, avoiding a surgical incision entirely.

For peripheral nerve sheath tumors, the results have been impressive. A large retrospective study found that ultrasound-guided core needle biopsy correctly distinguished malignant from benign tumors in over 99% of cases, with a sensitivity above 90% for detecting malignancy and a specificity of 100%. Complications were minimal: only one patient reported mild tingling that resolved within two days.¹⁹ For nerve tumor centers, this has become a game-changer, allowing diagnosis without the risks of open surgery on a nerve that may not need to be removed.²⁰

The picture is less clear for using needle biopsy to diagnose neuropathies like vasculitis. A case report described a technically successful ultrasound-guided sural nerve needle biopsy in a patient with suspected vasculitic neuropathy, but it did not yield a definitive result, similar to many surgical biopsies in the same setting.²¹ The smaller tissue sample obtained by needle may simply not be enough when the disease process is patchy. Still, the potential advantages of a percutaneous procedure, including lower complication rates, no surgical wound, and the option to repeat it, have generated interest in further investigation.

Skin Biopsy as an Alternative

For one major category of neuropathy, nerve biopsy has largely been replaced. Small fiber neuropathy, which affects the thinnest unmyelinated nerve fibers and causes burning pain, temperature sensitivity, and autonomic symptoms, cannot be detected by standard nerve conduction studies. A traditional nerve biopsy could theoretically show reduced unmyelinated fiber counts under electron microscopy, but the process is time-consuming and the nerve is sacrificed.

Skin biopsy offers a far simpler path. A tiny 3-millimeter punch biopsy is taken from the skin of the lower leg, and the density of nerve fibers within the skin’s outer layer is counted using immunohistochemical staining. Multiple studies have shown that reduced intraepidermal nerve fiber density reliably identifies small fiber neuropathy, with diagnostic sensitivity in the range of 80% to 90% and specificity around 90%. Because the procedure is minimally invasive, heals quickly, and can be repeated at different sites to track the disease over time, it has become the go-to diagnostic tool for small fiber neuropathy in most clinical settings.²²

Skin biopsy does not, however, replace nerve biopsy for conditions that primarily affect larger myelinated fibers or the nerve’s blood vessels. Vasculitis, amyloid deposits, demyelination, and tumors are invisible on a skin punch biopsy. The two procedures answer fundamentally different diagnostic questions, and knowing which question needs to be answered is how clinicians decide which biopsy to pursue.

Who Should Not Have a Nerve Biopsy

There are no absolute contraindications specific to nerve biopsy beyond those that apply to any minor surgical procedure, such as uncontrolled bleeding disorders or active infection at the biopsy site. But there are strong relative contraindications worth discussing. Patients who already have severe neuropathy in the leg being considered for biopsy may not benefit, because the nerve tissue may be so damaged that it is difficult to interpret. Conversely, if the diagnosis can be reached through less invasive means, like skin biopsy for small fiber neuropathy or genetic testing for hereditary neuropathies, there is little justification for an open nerve biopsy.

Perhaps the most important consideration is the expected yield. Nerve biopsy is at its most useful when there is a focused clinical question: “Is this vasculitis?” or “Is this amyloidosis?” It performs poorly as a fishing expedition. When clinicians send a biopsy hoping that “something will show up,” the odds of an informative result drop sharply. The best outcomes come from close collaboration between the neurologist and the neuropathologist before the procedure, agreeing on what they expect to find and which laboratory techniques should be prioritized for the specimen. A biopsy sent to a general pathology lab without neuropathology expertise may miss findings that a specialized center would catch, making the patient’s sacrifice of a functioning nerve an especially poor trade.